Moderna Inc. Stock Rises 6.9%, Outperforms Peers

Dow Jones2026/10/05 20:33

By:Dow Jones

This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Moderna Inc. advanced 6.9% to $203.21 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 27,477.31 and the Dow Jones Industrial Average rising 0.2% to 51,267.90. This was the stock's second consecutive day of gains. Moderna Inc. closed 2.7% below its 52-week high of $208.90, which the company reached on September 29th. The stock outperformed some of its peers, as Johnson & Johnson fell 1.2% to $252.93, Pfizer Inc. fell 1.4% to $27.41, and Gilead Sciences Inc. fell 0.08% to $144.63. Trading volume totaled 18.8 million, compared to the 50-day average of 20.1 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 05, 2026 16:33 ET (20:33 GMT)

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.